GILD vs. AMGN

In the year-to-date period, GILD achieves a 12.70% return, which is significantly higher than AMGN's 0.64% return. Over the past 10 years, GILD has underperformed AMGN with an annualized return of 2.02%, while AMGN has yielded a comparatively higher 8.71% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Gilead Sciences, Inc. (GILD) and Amgen Inc. (AMGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current GILD Sharpe Ratio is 0.95, which is higher than the AMGN Sharpe Ratio of 0.31. The chart below compares the historical Sharpe Ratios of GILD and AMGN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

GILD's dividend yield for the trailing twelve months is around 3.46%, more than AMGN's 3.17% yield.

The maximum GILD drawdown since its inception was -70.82%, smaller than the maximum AMGN drawdown of -78.04%. Use the drawdown chart below to compare losses from any high point for GILD and AMGN. For additional features, visit the drawdowns tool.

Gilead Sciences, Inc. (GILD) and Amgen Inc. (AMGN) have volatilities of 9.56% and 9.25%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Gilead Sciences, Inc. and Amgen Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.